Late-Quarter Infuse Headwinds Blunt Medtronic’s Growth

By Mike Evers

Medtronic’s FY3Q20 growth was surprisingly light due to headwinds around Infuse orders, but the enabling technology continues to drive implant sales.

Member-Only Content

SUBSCRIBE Login

Product Labels: PRP/Cell-Based/Osteoinductive Materials, Surgical Navigation, Robot-Assisted Systems, Spinal Fusion

Tags: Revenue Report